Gamida Cell (NASDAQ:GMDA – Get Free Report) will announce its earnings results before the market opens on Tuesday, November 14th. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Gamida Cell (NASDAQ:GMDA – Get Free […]
Gamida Cell Ltd. shared new data on the impact of the company?s proprietary nicotinamide technology on its allogeneic stem cell therapy omidubicel and investigational natural killer cell therapy.
BOSTON, Nov. 04, 2023 Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company’s proprietary nicotinamide .